The Clorox Company (NYSE:CLX) Shares Acquired by Geode Capital Management LLC

Geode Capital Management LLC lifted its stake in shares of The Clorox Company (NYSE:CLX) by 1.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,028,333 shares of the company’s stock after purchasing an additional 33,970 shares during the quarter. Geode Capital Management LLC owned about 2.45% of Clorox worth $491,713,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in CLX. Catalyst Capital Advisors LLC acquired a new stake in shares of Clorox in the 3rd quarter worth approximately $54,000. Raymond James & Associates boosted its stake in shares of Clorox by 32.8% during the 2nd quarter. Raymond James & Associates now owns 267,632 shares of the company’s stock valued at $36,524,000 after buying an additional 66,149 shares during the period. AQR Capital Management LLC raised its stake in shares of Clorox by 8.6% during the 2nd quarter. AQR Capital Management LLC now owns 287,277 shares of the company’s stock worth $39,121,000 after purchasing an additional 22,676 shares in the last quarter. Los Angeles Capital Management LLC raised its position in Clorox by 5.6% during the third quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock valued at $31,266,000 after acquiring an additional 10,149 shares in the last quarter. Finally, Assenagon Asset Management S.A. lifted its stake in shares of Clorox by 371.4% in the 2nd quarter. Assenagon Asset Management S.A. now owns 96,969 shares of the company’s stock valued at $13,233,000 after purchasing an additional 76,397 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Up 0.0 %

Shares of CLX stock opened at $164.68 on Friday. The company has a market capitalization of $20.38 billion, a price-to-earnings ratio of 57.38, a P/E/G ratio of 3.08 and a beta of 0.42. The firm has a fifty day moving average of $163.63 and a 200-day moving average of $151.21. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last released its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business’s quarterly revenue was up 27.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.49 EPS. As a group, equities research analysts predict that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.96%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio is currently 170.03%.

Wall Street Analyst Weigh In

CLX has been the subject of a number of analyst reports. DA Davidson boosted their price objective on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. JPMorgan Chase & Co. upped their price target on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research report on Friday, October 11th. Barclays boosted their price objective on Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research note on Friday, November 1st. Evercore ISI dropped their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. Finally, TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and raised their target price for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Five analysts have rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $155.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.